STAT+: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Category: clinical trials
STAT+: Altimmune’s obesity drug fails to stand out from blockbuster treatments in early data
A new obesity treatment being developed by Altimmune met goals for weight loss in a…
Watch: P-value, an important measurement in clinical trials, explained
When testing new treatments, drugmakers must show that their formulation bears out better results than…
STAT+: Many pediatric drug study results were never posted to a U.S. government database
Amid ongoing controversy over clinical trial transparency, a new analysis found that results of 43…
.jpg)
STAT+: Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported
A Democratic lawmaker is demanding to know what steps the U.S. Food and Drug Administration…
STAT+: Verily leans into Onduo as it looks to enter the lucrative world of running medical research
The new, streamlined Verily will have one very recognizable component: its virtual care company Onduo,…
STAT+: Ongoing problems with a new European clinical trial registry could cause ‘catastrophe’
A coalition of pharmaceutical industry and academic medical research associations based in Germany is calling…
STAT+: Novartis develops CAR-T therapy that can be made in a fraction of the standard time
NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer…
‘All the tech in the world doesn’t solve this’: Rare disease experts push biopharma on equity
Over the past few years, the biopharmaceutical industry has revved up efforts to diversify clinical…
STAT+: In ‘landmark’ study, cell therapy exceeds expectations in melanoma patients
When tumors like melanoma form, the immune system mobilizes for war. White blood cells called…
STAT+: Prometheus’ inflammatory bowel drug succeeds in two mid-stage trials
An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2…
STAT+: The secret to longer, healthier life? Ambitious new trial focuses on ‘super agers’ and seeks thousands of families.
Dr. Thomas Perls has for decades studied so-called super agers, people who live deep into their 90s…
En la frontera entre Texas y México, nace un audaz plan para diversificar la investigación sobre el Alzheimer
Read in English | Leer en inglés. BROWNSVILLE, Texas — Gladys Maestre está en una…
STAT+: After years of lax oversight, the NIH is starting to contact institutions about unreported clinical trial results
In recent weeks, the U.S. National Institutes of Health has begun emailing academic institutions that…
Here’s why we’re not prepared for the next wave of biotech innovation
The first time I remember hearing the words “biology’s century,” it was a sales pitch….
‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability
The hype around psychedelic therapy has been put to the test, with the publication Wednesday…
STAT+: Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical…
‘It still prevented cancers’: Experts discuss furor over colonoscopy study and dissect the nuances
On Sunday, the New England Journal of Medicine published the interim results of a landmark…
STAT+: At Verily, a growing line of business builds on a revolving door to the FDA
After years spent building a seemingly slapdash set of medical initiatives, Verily seems to have…
STAT+: Health app companies wrestle with how to design studies to prove treatments work
For companies that have spent years developing interactive technologies to help treat disease, the tricky…
On the Texas-Mexico border, a bold plan to diversify Alzheimer’s research takes shape
BROWNSVILLE, Texas — Gladys Maestre is on a scouting mission. The Alzheimer’s disease researcher is…
STAT+: Some European regulators are starting to take steps to ensure clinical trial results are reported
Regulators in half a dozen European countries are now taking steps to enforce requirements that…
STAT+: New details on Apple Watch study emphasize Medicaid enrollment
Newly published details about a high-profile Apple Watch study calls it “a priority” to recruit…
House Democrat presses bill to encourage more diversity in clinical trials run by NIH
Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues…
STAT+: Cancer treatment devised in the 1980s has proven effective (again). Will it finally get approval?
Eight years ago, a Dutch oncologist, John Haanen, set out to change melanoma treatment by…
STAT+: What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency
Amid ongoing controversy over clinical trial transparency, a new analysis found that just 3% of…
STAT+: ‘A blind eye’: NIH fails to ensure clinical trial results are reported and funds researchers who don’t file results
The U.S. National Institutes of Health failed to ensure that results of roughly half of…
Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach
Karuna Therapeutics said Monday that a novel combination pill reduced psychosis and related symptoms experienced…
Monoclonal antibody treatment for malaria shows encouraging results
An experimental antibody treatment prevented malaria in the majority of participants in a small but…
The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients
TRIALS AND TRUST: This is the second part of a series on health equity and…
STAT+: Major European research funders often fail to set policies or monitor progress on clinical trial transparency
Nearly two dozen major organizations that fund medical research in Europe often failed to set…
Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk
It’s a problem so complex, so fraught with stigma and treatment complications, that innovation has…
Remote technology could nudge patients to join cancer clinical trials
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
TRIALS AND TRUST: This is the first part of a series on health equity and…
STAT+: The World Health Assembly moves to bolster clinical trials, but some say it falls short
In response to the Covid-19 pandemic, the World Health Assembly adopted a resolution designed to…
.jpg)
STAT+: When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
Experts are predicting a coming surge of mergers and acquisitions in biotech. And if history…
STAT+: Race is often overlooked in key clinical trial data used to win new drug approvals in Europe
Just two-thirds of the pivotal clinical trials that were used to win prescription drug approvals…
STAT+: In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials
Ahead of a World Health Assembly meeting in May, the United Kingdom is circulating a…
Opinion: Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?
Sneha Dave has been living with a chronic disease for 17 years — almost her…
New Covid trial results may point toward better ways to study medicines
The battle against Covid-19 has been marked by false hope, as too many people embraced…
STAT+: ‘Harmful and wasteful’: Many pediatric clinical trials end early or don’t report results
An extensive analysis of thousands of pediatric trials found one in 10 ended early —…
Virtual Event: Taking the pulse of clinical trials
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Political pressure in the U.K. prompted more universities to report clinical trial results
Sometimes, sabre rattling works. Three years ago, a U.K. Parliamentary committee chair warned dozens of…
Robert Califf is a fervent believer in data. At the FDA, will that be enough?
At his confirmation hearing last month to lead the Food and Drug Administration, Robert Califf…
STAT+: Verily shakes up its leadership team, with a new president and a shift for CEO Conrad
Alphabet’s life sciences arm Verily is in the midst of a shakeup of its leadership….
Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most
If a drug maker tested an asthma treatment in children and found it significantly reduced…
STAT+: When FDA rattles its sabre, drug makers and universities start reporting overdue trial results
Over the past eight years, more than 90% of drug makers and universities that received…
STAT+: FDA warns a hospital and two physicians for putting patients at ‘significantly increased’ risk in trials
In harsh tones, U.S. regulators warned a Minnesota hospital and two of its physicians for…
STAT+: Pulling back the curtain: U.K. to launch new system for registering clinical trials automatically
In its latest bid to boost clinical trial transparency, the U.K. government will automatically register…